BRPI0716830A2 - Composto, composição, uso de um composto, métodos de contracepção, de terapia de reposição hormonal, de tratar um distúrbio ginecológico, e de produzir um composto - Google Patents

Composto, composição, uso de um composto, métodos de contracepção, de terapia de reposição hormonal, de tratar um distúrbio ginecológico, e de produzir um composto Download PDF

Info

Publication number
BRPI0716830A2
BRPI0716830A2 BRPI0716830-6A BRPI0716830A BRPI0716830A2 BR PI0716830 A2 BRPI0716830 A2 BR PI0716830A2 BR PI0716830 A BRPI0716830 A BR PI0716830A BR PI0716830 A2 BRPI0716830 A2 BR PI0716830A2
Authority
BR
Brazil
Prior art keywords
compound
mmol
cis
bromo
formula
Prior art date
Application number
BRPI0716830-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Johannes Bernardus Maria Rewinkel
Brigitte Johanna Bernita Folmer
Maria Lourdes Ollero-Ollero
Hemen Ibrahim
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of BRPI0716830A2 publication Critical patent/BRPI0716830A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0716830-6A 2006-09-27 2007-09-26 Composto, composição, uso de um composto, métodos de contracepção, de terapia de reposição hormonal, de tratar um distúrbio ginecológico, e de produzir um composto BRPI0716830A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP061213724 2006-09-27
EP06121372 2006-09-27
PCT/EP2007/060225 WO2008037746A1 (en) 2006-09-27 2007-09-26 Pyridooxazepine progesteron receptor modulators

Publications (1)

Publication Number Publication Date
BRPI0716830A2 true BRPI0716830A2 (pt) 2013-11-05

Family

ID=37813577

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716830-6A BRPI0716830A2 (pt) 2006-09-27 2007-09-26 Composto, composição, uso de um composto, métodos de contracepção, de terapia de reposição hormonal, de tratar um distúrbio ginecológico, e de produzir um composto

Country Status (27)

Country Link
EP (1) EP2066677B1 (de)
JP (1) JP2010504943A (de)
KR (1) KR20090064454A (de)
CN (1) CN101522689B (de)
AR (1) AR063018A1 (de)
AT (1) ATE478078T1 (de)
AU (1) AU2007302007B2 (de)
BR (1) BRPI0716830A2 (de)
CA (1) CA2664120A1 (de)
CL (1) CL2007002788A1 (de)
CO (1) CO6160325A2 (de)
CY (1) CY1110846T1 (de)
DE (1) DE602007008589D1 (de)
DK (1) DK2066677T3 (de)
ES (1) ES2349325T3 (de)
HR (1) HRP20100526T1 (de)
IL (1) IL197365A0 (de)
MX (1) MX2009002804A (de)
NO (1) NO20091016L (de)
NZ (1) NZ575276A (de)
PE (1) PE20071451A1 (de)
PL (1) PL2066677T3 (de)
PT (1) PT2066677E (de)
RU (1) RU2009115643A (de)
SI (1) SI2066677T1 (de)
TW (1) TW200820975A (de)
WO (1) WO2008037746A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
CN101200429B (zh) * 2006-12-13 2012-08-22 上海睿智化学研究有限公司 2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004508373A (ja) * 2000-09-07 2004-03-18 バイエル・フアーマシユーチカルズ・コーポレーシヨン 環式および非環式アミジンおよびプロゲステロン受容体結合剤として使用するためのそれらを含有する医薬組成物
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators

Also Published As

Publication number Publication date
CA2664120A1 (en) 2008-04-03
PT2066677E (pt) 2010-11-10
JP2010504943A (ja) 2010-02-18
PE20071451A1 (es) 2008-10-30
CL2007002788A1 (es) 2008-04-18
AR063018A1 (es) 2008-12-23
AU2007302007B2 (en) 2012-02-02
CN101522689B (zh) 2012-01-11
EP2066677B1 (de) 2010-08-18
HK1126767A1 (en) 2009-09-11
SI2066677T1 (sl) 2010-12-31
DK2066677T3 (da) 2010-11-08
AU2007302007A1 (en) 2008-04-03
RU2009115643A (ru) 2010-11-10
TW200820975A (en) 2008-05-16
CY1110846T1 (el) 2015-06-10
HRP20100526T1 (hr) 2010-11-30
EP2066677A1 (de) 2009-06-10
CO6160325A2 (es) 2010-05-20
PL2066677T3 (pl) 2011-02-28
KR20090064454A (ko) 2009-06-18
WO2008037746A1 (en) 2008-04-03
CN101522689A (zh) 2009-09-02
ATE478078T1 (de) 2010-09-15
NZ575276A (en) 2011-07-29
NO20091016L (no) 2009-03-30
IL197365A0 (en) 2009-12-24
MX2009002804A (es) 2009-03-31
DE602007008589D1 (de) 2010-09-30
ES2349325T3 (es) 2010-12-30

Similar Documents

Publication Publication Date Title
WO2019147783A1 (en) Sulfonamide derivatives for protein degradation
EP2802320B1 (de) Tricyclische verbindungen, zusammensetzungen damit und verwendungen davon
BRPI0917923A2 (pt) derivados de ácido tricíclico substituído como agonista de receptor s1p1 úteis no tratamento de distúrbios autoimunes e inflamatórios
JP2012505885A (ja) レボドパエステルプロドラッグを合成する方法
JP2025530932A (ja) カンプトテシン－７－エチルアミン誘導体、及びその調製方法、並びに使用
WO2017136769A1 (en) Peptide drug conjugates
LT3604B (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
ES3055912T3 (en) Efficient process for making 6-carboxy benzoxazole derivatives
BRPI0716830A2 (pt) Composto, composição, uso de um composto, métodos de contracepção, de terapia de reposição hormonal, de tratar um distúrbio ginecológico, e de produzir um composto
JP2022553833A (ja) エストロゲン受容体調節薬の塩及び形態
TWI905090B (zh) Mcl-1抑制劑之新結晶型, 其製備方法及包含其之醫藥組合物
CN111918859B (zh) 稠合三环γ-氨基酸衍生物的盐的晶型及制备和应用
US7989442B2 (en) Progesterone receptor modulators
WO2021104413A1 (zh) 稠合吡啶环衍生物、其制备方法及其在医药上的应用
IL324475A (en) Deuterium-containing camptothecin compound, method for its preparation and use
AU2023280622A1 (en) Compounds
HK1126767B (en) Pyridooxazepine progesteron receptor modulators
WO2026008076A1 (zh) 含一氧化氮供体的黄酮类衍生物
KR20100021438A (ko) 신규한 프로게스테론 수용체 조절제
HK40130194A (zh) 含一氧化氮供体的黄酮类衍生物
WO2025067474A1 (zh) 一种含吡啶的化合物及其制备方法和用途
HK40122848A (zh) 双取代酰胺卟啉衍生物、其制备方法及其作为光敏剂的用途
HK40122848B (zh) 双取代酰胺卟啉衍生物、其制备方法及其作为光敏剂的用途
EA044230B1 (ru) Новые кристаллические формы mcl-1 ингибитора, способ их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.